ME/CFS Research Foundation Logo

Exploring the Glycome: Identifying Glycosylation-Related Biomarkers for severity stratification in Chronic Fatigue Syndrome

About

Status:
Ongoing
Principal investigator:
Country:
Austria
Study start:
2025-01
Completion (planned):
2025-12
Last update:
2024-12-10

 

Research types:
Basic research
Research areas:
Immune system dysfunction
Interventions:
Not applicable
Priv. Sector Partner:
Not available
Sponsors:

Project description

Post-infectious ME/CFS is a systemic inflammatory condition characterised by severe fatigue, sleep disturbances, intestinal problems and post-exertional malaise (PEM). The cause of the pathology remains elusive and for this reason, treating ME/CSF symptoms remains difficult.

In this project, the investigators will test the hypothesis that changes in glycosylation in the peripheral blood of ME/CFS patients are a useful novel biomarker for severity stratification of ME/CFS patients during episodes of PEM and general fatigue. Proper glycosylation helps maintain immune tolerance, while improper glycosylation can lead to inflammation and autoimmunity. The enhanced pro-inflammatory state in post-infectious ME/CFS might lead to a hypo-glycosylated state in the body, which might result in inflammatory immune responses. The investigators will use advanced mass spectrometry to detect changes in sialic acid, O- , N- glycosylation and antibody N-glycosylation as surrogate markers for the damage at the glycocalyx in the peripheral blood of post-infectious ME/CFS patients.

Furthermore, they project team will assess the inflammatory capacity of aberrantly glycosylated antibodies in vitro. Combining their complementary, interdisciplinary expertise of analytical /synthetic chemistry/autoimmunity (Davide Ret) and immunology in the field of rheumatology and autoimmune diseases (Selina Keppler) will enable them to address the biochemical changes as well as the biological implications of aberrant glycosylation during post-infectious ME/CFS. Depending on their results, the investigators will work on approaches on how to mitigate and restore aberrant glycosylation using interventions such as sugar supplements or enzyme inhibitors in future follow-up studies. A better understanding of the biological triggers and markers for severity stratification is an important step towards better treatment options.

(Description adapted from project website: see link above)

Patient cohort

Not available.

Patients enrolled: Not available

Age group: Not available

Research areas
3
Research types
1
Research networks
0
Working groups
1
People
2
Publications
0
Organisations
3